1. CD1d-restricted peripheral T cell lymphoma in mice and humans.
- Author
-
Bachy E, Urb M, Chandra S, Robinot R, Bricard G, de Bernard S, Traverse-Glehen A, Gazzo S, Blond O, Khurana A, Baseggio L, Heavican T, Ffrench M, Crispatzu G, Mondière P, Schrader A, Taillardet M, Thaunat O, Martin N, Dalle S, Le Garff-Tavernier M, Salles G, Lachuer J, Hermine O, Asnafi V, Roussel M, Lamy T, Herling M, Iqbal J, Buffat L, Marche PN, Gaulard P, Kronenberg M, Defrance T, and Genestier L
- Subjects
- Animals, Antigens, CD1d genetics, Antigens, Ly genetics, Antigens, Ly immunology, Female, Humans, Lymphoma, T-Cell, Peripheral genetics, Lymphoma, T-Cell, Peripheral pathology, Male, Mice, Mice, Knockout, NK Cell Lectin-Like Receptor Subfamily B genetics, NK Cell Lectin-Like Receptor Subfamily B immunology, Receptors, Antigen, T-Cell genetics, Receptors, Antigen, T-Cell immunology, Signal Transduction genetics, Streptococcus pneumoniae immunology, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 immunology, Antigens, CD1d immunology, Lymphoma, T-Cell, Peripheral immunology, Signal Transduction immunology
- Abstract
Peripheral T cell lymphomas (PTCLs) are a heterogeneous entity of neoplasms with poor prognosis, lack of effective therapies, and a largely unknown pathophysiology. Identifying the mechanism of lymphomagenesis and cell-of-origin from which PTCLs arise is crucial for the development of efficient treatment strategies. In addition to the well-described thymic lymphomas, we found that p53-deficient mice also developed mature PTCLs that did not originate from conventional T cells but from CD1d-restricted NKT cells. PTCLs showed phenotypic features of activated NKT cells, such as PD-1 up-regulation and loss of NK1.1 expression. Injections of heat-killed Streptococcus pneumonia, known to express glycolipid antigens activating NKT cells, increased the incidence of these PTCLs, whereas Escherichia coli injection did not. Gene expression profile analyses indicated a significant down-regulation of genes in the TCR signaling pathway in PTCL, a common feature of chronically activated T cells. Targeting TCR signaling pathway in lymphoma cells, either with cyclosporine A or anti-CD1d blocking antibody, prolonged mice survival. Importantly, we identified human CD1d-restricted lymphoma cells within Vδ1 TCR-expressing PTCL. These results define a new subtype of PTCL and pave the way for the development of blocking anti-CD1d antibody for therapeutic purposes in humans., (© 2016 Bachy et al.)
- Published
- 2016
- Full Text
- View/download PDF